Tonix Pharmaceuticals dhia 25%, thiab ntawm no yog vim li cas

Tonix Pharmaceuticals Corp.NASDAQ: TNXP) tau nce 25% tom qab tshaj tawm tias US Patent thiab Trademark Office tau muab nws US Patent No. 11,342,896 rau lub Tsib Hlis 31, 2022. Cov patent yog hu ua "Synthetic Chimeric Poxviruses," Nws npog cov kab mob kab mob kab mob, uas yog lub hauv paus ntawm cov Cov tshuaj tiv thaiv TNX-801 lub tuam txhab tab tom tsim rau cov kab mob me me thiab cov kab mob liab, Recombinant Pox Virus platform, uas tiv thaiv cov kab mob xws li SARS.

patent muab Tonix kev lag luam tshwj xeeb hauv Asmeskas

Qhov patent no yog npaj los muab Tonix kev lag luam monopoly hauv Tebchaws Meskas kom txog rau thaum 2037, tsis suav nrog kev xav tau patent txoj cai txuas ntxiv lossis hloov pauv. patent yog ib kauj ruam tseem ceeb hauv kev tiv thaiv lub tuam txhab kev loj hlob ntawm cov tshuaj tiv thaiv tiv thaiv kab mob uas twb muaj lawm thiab muaj peev xwm tshiab.

Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?

Sau npe rau Invezz cov ntawv xov xwm, hnub no.

CEO Tonix Pharmaceuticals Seth Lederman tau hais tias:

TNX-801 yog cov tshuaj tiv thaiv kab mob uas muaj kab mob nyob rau hauv horsepox nyob rau hauv kev tsim kho tam sim no los tiv thaiv tus kab mob liab thiab kab mob me. Tsis tas li ntawd, TNX-18401 thiab TNX-18501 yog tsim los nthuav qhia cov protein ntau los ntawm SARS-CoV-2 omicron thiab BA.2 variants, feem. Horsepox yog ib qho ntawm thawj ob peb tus kab mob uas tau tsim los ntawm cov kab mob hluavtaws thiab tseem nyob hauv cov loj tshaj plaws.

Thawj Tswj Hwm tau hais ntxiv tias lawv zoo siab tau txais daim ntawv pov thawj tshiab, uas yog ib feem ntawm lub tuam txhab patent vaj tse, raws li lawv tau ua tiav cov tshuaj tiv thaiv kab mob nyob hauv tus kab mob horsepox mus rau kev kho mob.

TNX-801 yog ib qho tshuaj tiv thaiv kab mob horsepox nyob rau hauv lub tuam txhab tab tom tsim rau kev tswj xyuas percutaneous tiv thaiv kab mob me thiab kab mob liab. Lub tuam txhab tau tshaj tawm yav dhau los txhawb cov txiaj ntsig los ntawm kev tshawb fawb kev sib tw liab hauv cov qauv tsiaj.

Tonix tab tom tsim cov tshuaj tiv thaiv COVID-19, TNX-1850 thiab TNX-1840.

Dhau li ntawm TNX-801, lub tuam txhab tseem tab tom tsim TNX-1850 thiab TNX-1840 los tiv thaiv COVID-19. Tonix tau tsim TNX-1840 thiab TNX-1850 los ua kom pom cov protein ntau nyob hauv BA.2 thiab Omicron variants ntawm tus kab mob SARS-CoV-2. Tonix tau tshaj tawm yav dhau los txhawb cov txiaj ntsig los ntawm SARS-CoV-2 kev sib tw sim hauv cov neeg tsis yog tib neeg apes. Cov tsiaj tau txhaj tshuaj nrog cov tshuaj tiv thaiv kab mob horsepox-based TNX-1800 uas qhia txog Wuhan strain's spike protein.

Tus kab mob horsepox thiab cov tshuaj tiv thaiv raws li nws yog lub tsheb yog nyob replicating cov kab mob eliciting robust teb. Cov kab mob no, xws li kab mob horsepox thiab tshuaj tiv thaiv, tuaj yeem hloov kho caj ces los qhia cov noob txawv teb chaws thiab tau siv rau hauv cov tshuaj tiv thaiv kab mob.